Company attributes
Venture Capital Firm attributes
Other attributes
Hopen Life Science Ventures is a Grand Rapids, Michigan and Westlake, Ohio based venture capital firm. They invest in early to mid-stage life sciences companies, especially in medical devices, diagnostics, therapeutics, healthcare information technology, and drug discovery enabling technology sectors. Hopen Life Science Ventures prefers to invest in the Midwest of the United States, feeling this is a market under-served by venture capital firms.
Hopen Life Science Ventures offers their portfolio companies funding, developmental and managerial experience and support as well as an industry network.
Hopen Life Science Ventures has made investments in Cirius Therapeutics, Delphinus Medical Technologies, NeoChord, Sierra Oncology, Tolera Therapeutics, Bjond and Prevacept Infection Control.
They have exited their investment in Sierra Oncology.
